PACBVSSFWL• 12 Months (Normalized)
PACB vs SFWL (Pacific Biosciences of California Inc. vs Shengfeng Development Limited)
Showing Closing Date Range from Oct 6, 2025 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
PACB Performance $2.7
+77.63%
Pacific Biosciences of California Inc.
Normalized Baseline0.00%
SFWL Performance $9
+800.9%
Shengfeng Development Limited
Normalized Baseline0.00%
Alpha Spread Margin SFWL LEADS
-723.27 pts
SFWL outperforming by 723.27 percentage points
PACBSFWL
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
PACB SFWL
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | PACB Price | PACB Gain (%) | SFWL Price | SFWL Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $2.70 | +77.63% | $9.00 | +800.90% | -723.27% |
| Oct 05, 2026 | $2.87 | +88.82% | $8.82 | +782.88% | -694.06% |
| Oct 02, 2026 | $2.54 | +67.11% | $8.35 | +735.84% | -668.73% |
| Oct 01, 2026 | $2.51 | +65.13% | $8.81 | +781.88% | -716.75% |
| Sep 30, 2026 | $2.37 | +55.92% | $8.90 | +790.89% | -734.97% |
| Sep 29, 2026 | $1.83 | +20.39% | $8.90 | +790.89% | -770.50% |
| Sep 28, 2026 | $1.71 | +12.50% | $8.90 | +790.89% | -778.39% |
| Sep 24, 2026 | $1.46 | -4.28% | $- | - | |
| Sep 23, 2026 | $1.41 | -7.24% | $8.48 | +748.85% | -756.09% |
| Sep 22, 2026 | $- | $8.83 | +783.38% | - | |
| Sep 21, 2026 | $1.36 | -10.53% | $8.48 | +748.85% | -759.38% |
| Sep 18, 2026 | $1.37 | -9.87% | $8.28 | +728.73% | -738.60% |
| Sep 17, 2026 | $1.38 | -9.21% | $9.00 | +800.40% | -809.61% |
| Sep 16, 2026 | $1.34 | -11.84% | $9.00 | +800.90% | -812.74% |
| Sep 15, 2026 | $1.34 | -11.84% | $9.20 | +820.92% | -832.76% |
Page 1 of 17